News
-
Swedish DPI company Iconovo has announced a licensing and development deal with generics manufacturer Amneal Pharmaceuticals for a generic dry powder asthma/COPD therapy delivered by Iconovo’s ICOres multidose DPI. According to the company, the deal… Read more . . .
-
MannKind Corporation has announced that it signed an agreement with JDRF (formerly the Juvenile Diabetes Research Foundation) to collaborate on research focused on the use of Afrezza inhaled insulin in pediatric diabetes patients. JDRF is… Read more . . .
-
Device developer and manufacturer Phillips-Medisize has acquired Danish device company Medicom Innovation Partner (formerly Bang & Olufsen Medicom) for an undisclosed amount. The company said that, “The addition of Medicom’s capabilities expands Phillips-Medisize’s end-to-end injectable… Read more . . .
-
Acorda Therapeutics will present data from a Phase 1 study of its CVT-427 zolmitriptan DPI at the Annual Scientific Meeting of the American Headache Society, the company has announced. According to the company, the data… Read more . . .
-
Insmed has announced the withdrawal of its marketing authorization application for Arikayce inhaled liposomal amikacin for the treatment of nontuberculous mycobacteria (NTM) lung disease. The MAA was submitted to the European Medicines Agency in 2014,… Read more . . .
-
Chiesi says that it is on track with planned regulatory submissions in the EU for its ICS/LAMA/LABA MDI for the treatment of COPD by the end of 2016 after successful completion of two 12-month Phase… Read more . . .
-
Spray-drying and DPI specialist Hovione announced the opening a new sales and customer support office in Osaka, Japan, saying that “The new office underlines the importance of Japan for Hovione’s business activities. Japan is a… Read more . . .
-
GlaxoSmithKline plc (LSE:GSK) and Innoviva have announced that the planned submission of an NDA for a triple therapy DPI for the treatment of COPD has been moved up from the first half of 2018 to… Read more . . .
-
California-based Innovus Pharmaceuticals announced that it has signed a manufacturing agreement for its FlutiCare fluticasone propionate nasal spray in anticipation of FDA approval, which it expects in the 3rd quarter of 2016. No details were… Read more . . .
-
According to Teva Pharmaceutical, a decentralized procedure for its Braltus tiotropium bromide DPI for the treatment of COPD has reached “a positive conclusion.” The tiotropium formulation is delivered using the new Zonda inhaler, the company… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.